Records containing: Kidney Transplant Rejection

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2025-05-06
A Phase I/II Trial to Evaluate the Safety and Tolerability of Clazakizumab (Anti-IL-6 Monoclonal) As an Agent to Eliminate Donor Specific HLA Antibodies and Improve Outcomes of Patients With Chronic & Active Antibody-Mediated Rejection Post-Kidney Transplantation
CLINICAL_TRIALS study record update · 2025-04-24
Use of Donor-Derived Cell-Free DNA to Characterize Response to Therapy With Tocilizumab for Chronic Antibody-Mediated Rejection in Kidney Transplantation
CLINICAL_TRIALS study record update · 2025-04-13
A Multicentre Randomised Controlled Trial to Assess the Efficacy of Adding Rituximab to Standard of Care in Treating Acute Antibody-mediated Rejection in Kidney Transplantation
CLINICAL_TRIALS study record update · 2025-04-10
Impact of the Microbiota on the Likelihood of Renal Graft Rejection
CLINICAL_TRIALS study record update · 2025-04-09
Non-invasive Diagnosis and Management of Subclinical Rejection in Kidney Transplant Patients Using 18F-fluorodeoxy Glucose Positron Emission Tomography (18FDG-PET/CT)
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2025-04-08
Utilising Volumetric Absorptive Microsampling (VAMS®) Technology to Monitor Tacrolimus and Creatinine Concentrations in Adult Renal Transplant Patients
CLINICAL_TRIALS study record update · 2025-03-28
Improving KIdney ¬Transplantation with Cellular Therapy Study
CLINICAL_TRIALS study record update · 2025-03-28
GEnomic Medicine in Kidney Transplantation Study
CLINICAL_TRIALS study record update · 2025-03-14
A Phase 2, Randomized, Placebo-Controlled Study to Evaluate Fingolimod for the Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation
CLINICAL_TRIALS study record update · 2025-02-28
Autologous Tolerogenic Dendritic Cells (ATDC) for Highly Sensitized Kidney Transplant Recipients
CLINICAL_TRIALS study record update · 2025-02-13
Impact of Probiotic Supplementation on Urinary Tract Infections and Clinically Relevant Outcomes of Kidney Transplant Recipients
CLINICAL_TRIALS study record update · 2025-02-10
Multicentre Open-Label Single Ascending Dose Dose-Ranging Phase I/IIa Study to Evaluate Safety and Tolerability of an Autologous Antigen-Specific Chimeric Antigen Receptor TRegulatory Cell Therapy in Living Donor Renal Transplant Recipients
CLINICAL_TRIALS study record update · 2025-01-22
Donor-derived Cell-free DNA for Early Diagnosis of Antibody-mediated Rejection in Kidney Transplant Recipient with Donor-specific Antibodies
CLINICAL_TRIALS study record update · 2024-11-13
Efficacy of Achieving Early Target Trough Levels of Tacrolimus Using CYP3A5 Guided Dosing Versus Weight-based Dosing in a Multi-ethnic Population of Kidney Transplant Recipients in Singapore
CLINICAL_TRIALS study record update · 2024-10-31
An Integrative Clinicopathological Decision Support System for Kidney Transplant Rejection
CLINICAL_TRIALS study record update · 2024-10-04
Clinical Impact of the IBox As an Early Intervention TooL: a Prospective Randomised Controlled Trial to Assess the Use of a Software Predicting Allograft Survival in the Follow-up of Kidney Transplanted Patients.
CLINICAL_TRIALS study record update · 2024-08-30
Expanding the Scope of Post-transplant HLA-specific Antibody Detection and Monitoring in Renal Transplant Recipients
CLINICAL_TRIALS study record update · 2024-08-06
The PROspera Kidney Transplant ACTIVE Rejection Assessment Registry (ProActive)
CLINICAL_TRIALS study record update · 2024-07-11
Impact of Microvascular Inflammation on Kidney Allograft Outcome: a Multinational Cohort Study
CLINICAL_TRIALS study record update · 2024-07-10
A Prospective, Pilot Trial to Compare the Efficacy of Tacrolimus Extended-Release (Envarsus XR) to Tacrolimus Immediate-Release on Suppression of Donor-Specific Antibodies in HLA Sensitized Kidney Transplant Recipients
CLINICAL_TRIALS study record update · 2024-06-07
A Phase 2/3, Prospective, Randomized, Multi-center, Open-Label, Controlled Trial to Assess the Efficacy & Safety of Cellular Immunotherapy With MDR-102 for Induction of Immune Quiescence™in Recipients of HLA-mismatched, LD Kidney Transplants
CLINICAL_TRIALS study record update · 2024-06-07
A Phase 2 Prospective, Multi-center, Open-label Trial to Assess the Safety & Efficacy of Cellular Immunotherapy With MDR-103 for Induction of Mixed Chimerism & Immune Tolerance in Past Recipients of HLA Zero-mismatch, LD Kidney Transplants
CLINICAL_TRIALS study record update · 2024-06-07
A Phase 3, Randomized, Multi-center, Open-label, Controlled Trial to Assess the Efficacy and Safety of Cellular Immunotherapy With MDR-101 for Induction of Immune Tolerance in Recipients of HLA-matched, Living Donor Kidney Transplants
CLINICAL_TRIALS study record update · 2024-06-05
The EUropean TRAnsplantation and INnovation Consortium for Risk Stratification in Kidney Transplant Patients
CLINICAL_TRIALS study record update · 2024-04-04
Tacrolimus Exposure and Outcomes in Kidney Transplant Patients: A Retrospective Multicenter Study of Clinical Data Warehouse (CDW) in South Korea